Education
About Us
Working with TipRanks
Follow Us
Cosmo Bio Co., Ltd. (JP:3386)
:3386
3386 Stock Chart & Stats
¥1190.00
¥2.00(0.18%)
At close: 4:00 PM EST
¥1190.00
¥2.00(0.18%)
Day’s Range― - ―
52-Week Range¥971.00 - ¥1,486.00
Previous CloseN/A
Volume2.50K
Average Volume (3M)81.79K
Market Cap
¥7.63B
Enterprise Value¥4.90B
Total Cash (Recent Filing)¥3.19B
Total Debt (Recent Filing)¥20.00M
Price to Earnings (P/E)30.9
Beta0.34
Next Earnings
Feb 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.57%
Share Statistics
EPS (TTM)3.93
Shares Outstanding6,048,000
10 Day Avg. Volume21,560
30 Day Avg. Volume81,793
Financial Highlights & Ratios
PEG Ratio-0.59
Price to Book (P/B)0.70
Price to Sales (P/S)0.63
P/FCF Ratio251.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
3386 FAQ
What was Cosmo Bio Co., Ltd.’s price range in the past 12 months?
Cosmo Bio Co., Ltd. lowest stock price was ¥971.00 and its highest was ¥1486.00 in the past 12 months.
What is Cosmo Bio Co., Ltd.’s market cap?
Cosmo Bio Co., Ltd.’s market cap is ¥7.63B.
When is Cosmo Bio Co., Ltd.’s upcoming earnings report date?
Cosmo Bio Co., Ltd.’s upcoming earnings report date is Feb 13, 2026 which is in 29 days.
How were Cosmo Bio Co., Ltd.’s earnings last quarter?
Cosmo Bio Co., Ltd. released its earnings results on Nov 07, 2025. The company reported ¥3.93 earnings per share for the quarter, beating the consensus estimate of N/A by ¥3.93.
Is Cosmo Bio Co., Ltd. overvalued?
According to Wall Street analysts Cosmo Bio Co., Ltd.’s price is currently Overvalued.
Does Cosmo Bio Co., Ltd. pay dividends?
Cosmo Bio Co., Ltd. pays a Semiannually dividend of ¥25 which represents an annual dividend yield of 4.57%. See more information on Cosmo Bio Co., Ltd. dividends here
What is Cosmo Bio Co., Ltd.’s EPS estimate?
Cosmo Bio Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cosmo Bio Co., Ltd. have?
Cosmo Bio Co., Ltd. has 6,048,000 shares outstanding.
What happened to Cosmo Bio Co., Ltd.’s price movement after its last earnings report?
Cosmo Bio Co., Ltd. reported an EPS of ¥3.93 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cosmo Bio Co., Ltd.?
Currently, no hedge funds are holding shares in JP:3386
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cosmo Bio Co., Ltd.
Cosmo Bio Co., Ltd. (3386) is a biotechnology company based in Japan that specializes in the distribution of life science research products and laboratory supplies. The company operates primarily in the fields of biotechnology and pharmaceuticals, offering a wide range of products including reagents, antibodies, and diagnostic kits. Cosmo Bio serves a diverse clientele, including academic institutions, research organizations, and pharmaceutical companies, facilitating advancements in medical research and diagnostics.
Technical Analysis
Shin Nippon Biomedical Laboratories, Ltd.
―
Medrx Co., Ltd.
―
Oncolys BioPharma, Inc.
―
Perseus Proteomics, Inc.
―
Noile-Immune Biotech Inc.
―